pyridazine has been researched along with imidazole in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, M; Iguchi, Y; Iizuka, K; Kajiwara, I; Kawamura, M; Miyamoto, T; Nakazawa, M; Ohyama, I; Okada, T; Taniguchi, K; Tanouchi, T | 1 |
Fotsch, C; St Jean, DJ | 1 |
Ashida, Y; Fukuda, S; Gyoten, M; Kamei, T; Kawano, Y; Midoro, K; Nagaya, H | 1 |
Andrews, PS; Boezio, AA; Boezio, CM; Bush, TL; Cai, T; Cheng, AC; Choquette, D; Coats, JR; Colletti, AE; Copeland, KW; DuPont, M; Graceffa, R; Grubinska, B; Kim, JL; La, DS; Lewis, RT; Liu, J; Mullady, EL; Peterson, EA; Potashman, MH; Romero, K; Shaffer, PL; Stanton, MK; Stellwagen, JC; Teffera, Y; Yi, S | 1 |
1 review(s) available for pyridazine and imidazole
Article | Year |
---|---|
Mitigating heterocycle metabolism in drug discovery.
Topics: Animals; Biotransformation; Databases, Factual; Drug Discovery; Drug Interactions; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Pharmaceutical Preparations; Rats | 2012 |
3 other study(ies) available for pyridazine and imidazole
Article | Year |
---|---|
Highly selective inhibitors of thromboxane synthetase. 2. Pyridine derivatives.
Topics: Animals; Oxidoreductases; Pyridines; Sheep; Structure-Activity Relationship; Thromboxane-A Synthase | 1981 |
Inhibition of allergic dermal inflammation by the novel imidazopyridazine derivative TAK-427 in a guinea pig experimental model of eczema.
Topics: Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Dermatitis, Allergic Contact; Dexamethasone; Disease Models, Animal; Eczema; Female; Guinea Pigs; Histamine H1 Antagonists; Imidazoles; Male; Pyridazines; RNA, Messenger | 2002 |
Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors.
Topics: Animals; Benzimidazoles; Binding Sites; Binding, Competitive; Crystallography, X-Ray; Drug Design; Drug Evaluation, Preclinical; Half-Life; Humans; Imidazoles; Male; Mice; Microsomes, Liver; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyridazines; Pyridines; Rats, Sprague-Dawley; Signal Transduction; Structure-Activity Relationship; TOR Serine-Threonine Kinases | 2012 |